Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9ASZ1
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.515 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.514 |
CLV_PCSK_FUR_1 | 121 | 125 | PF00082 | 0.334 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.580 |
CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.620 |
CLV_PCSK_PC1ET2_1 | 220 | 222 | PF00082 | 0.584 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 285 | 289 | PF00082 | 0.502 |
DEG_SPOP_SBC_1 | 190 | 194 | PF00917 | 0.675 |
DOC_MAPK_gen_1 | 121 | 129 | PF00069 | 0.650 |
DOC_MAPK_gen_1 | 62 | 72 | PF00069 | 0.337 |
DOC_MAPK_MEF2A_6 | 121 | 129 | PF00069 | 0.650 |
DOC_MAPK_MEF2A_6 | 62 | 70 | PF00069 | 0.507 |
DOC_PP4_FxxP_1 | 119 | 122 | PF00568 | 0.541 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.736 |
DOC_USP7_MATH_1 | 275 | 279 | PF00917 | 0.476 |
LIG_14-3-3_CanoR_1 | 157 | 161 | PF00244 | 0.478 |
LIG_14-3-3_CterR_2 | 303 | 307 | PF00244 | 0.689 |
LIG_Actin_WH2_2 | 277 | 293 | PF00022 | 0.512 |
LIG_BIR_III_4 | 111 | 115 | PF00653 | 0.480 |
LIG_Clathr_ClatBox_1 | 236 | 240 | PF01394 | 0.495 |
LIG_CtBP_PxDLS_1 | 242 | 246 | PF00389 | 0.473 |
LIG_deltaCOP1_diTrp_1 | 146 | 150 | PF00928 | 0.513 |
LIG_deltaCOP1_diTrp_1 | 244 | 251 | PF00928 | 0.469 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.499 |
LIG_FHA_2 | 88 | 94 | PF00498 | 0.606 |
LIG_HCF-1_HBM_1 | 93 | 96 | PF13415 | 0.542 |
LIG_LIR_Gen_1 | 227 | 237 | PF02991 | 0.494 |
LIG_LIR_Gen_1 | 244 | 253 | PF02991 | 0.435 |
LIG_LIR_Gen_1 | 48 | 53 | PF02991 | 0.458 |
LIG_LIR_Gen_1 | 57 | 66 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 131 | 135 | PF02991 | 0.645 |
LIG_LIR_Nem_3 | 146 | 150 | PF02991 | 0.545 |
LIG_LIR_Nem_3 | 173 | 179 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 227 | 232 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 244 | 250 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 48 | 52 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 57 | 61 | PF02991 | 0.391 |
LIG_PCNA_yPIPBox_3 | 60 | 71 | PF02747 | 0.516 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.453 |
LIG_SH2_CRK | 58 | 62 | PF00017 | 0.498 |
LIG_SH2_CRK | 63 | 67 | PF00017 | 0.462 |
LIG_SH2_GRB2like | 98 | 101 | PF00017 | 0.340 |
LIG_SH2_NCK_1 | 132 | 136 | PF00017 | 0.418 |
LIG_SH2_NCK_1 | 172 | 176 | PF00017 | 0.479 |
LIG_SH2_NCK_1 | 98 | 102 | PF00017 | 0.339 |
LIG_SH2_STAP1 | 152 | 156 | PF00017 | 0.408 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.221 |
LIG_SH2_STAP1 | 272 | 276 | PF00017 | 0.519 |
LIG_SH2_STAP1 | 49 | 53 | PF00017 | 0.506 |
LIG_SH2_STAT3 | 152 | 155 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.425 |
LIG_SH3_3 | 122 | 128 | PF00018 | 0.665 |
LIG_SUMO_SIM_par_1 | 286 | 292 | PF11976 | 0.411 |
LIG_TRAF2_1 | 213 | 216 | PF00917 | 0.524 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.508 |
MOD_CK2_1 | 210 | 216 | PF00069 | 0.620 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.717 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.733 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.683 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.385 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.585 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.403 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.557 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.668 |
MOD_GSK3_1 | 299 | 306 | PF00069 | 0.614 |
MOD_N-GLC_1 | 101 | 106 | PF02516 | 0.474 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.671 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.756 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.682 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.396 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.499 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.495 |
MOD_PK_1 | 88 | 94 | PF00069 | 0.468 |
MOD_PKA_2 | 156 | 162 | PF00069 | 0.524 |
MOD_PKA_2 | 208 | 214 | PF00069 | 0.696 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.567 |
MOD_Plk_1 | 232 | 238 | PF00069 | 0.516 |
MOD_Plk_4 | 232 | 238 | PF00069 | 0.489 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.462 |
MOD_SUMO_rev_2 | 213 | 222 | PF00179 | 0.473 |
MOD_SUMO_rev_2 | 258 | 266 | PF00179 | 0.526 |
TRG_DiLeu_BaEn_1 | 185 | 190 | PF01217 | 0.595 |
TRG_DiLeu_BaEn_2 | 47 | 53 | PF01217 | 0.549 |
TRG_DiLeu_BaLyEn_6 | 63 | 68 | PF01217 | 0.459 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.614 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.476 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.497 |
TRG_ER_diArg_1 | 121 | 124 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 168 | 170 | PF00400 | 0.524 |
TRG_Pf-PMV_PEXEL_1 | 285 | 289 | PF00026 | 0.546 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I684 | Leptomonas seymouri | 65% | 93% |
A0A0S4JSE6 | Bodo saltans | 26% | 100% |
A0A1X0P7P0 | Trypanosomatidae | 27% | 100% |
A0A3S7XB03 | Leishmania donovani | 92% | 86% |
A0A422N520 | Trypanosoma rangeli | 25% | 100% |
A4HP83 | Leishmania braziliensis | 81% | 100% |
A4IDI8 | Leishmania infantum | 92% | 86% |
Q4Q1K7 | Leishmania major | 90% | 100% |
V5BKX8 | Trypanosoma cruzi | 26% | 100% |